Genmab A/S (GNMSF) Free cash flow 2023–2025
Genmab A/S (GNMSF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.1BFY2025 · since FY2023: $1.0B → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +4.5% |
| FY2024 | $1.1B | +8.0% |
| FY2023 | $1.0B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GNMSF financial trends
GNMSF RevenueGNMSF Net incomeGNMSF Net marginGNMSF Gross profitGNMSF Gross marginGNMSF Operating incomeGNMSF Operating marginGNMSF Operating cash flowGNMSF Capital expendituresGNMSF Return on equityGNMSF Stock buybacksGNMSF Dividends paidGNMSF Total assetsGNMSF Total liabilitiesGNMSF Shareholders’ equityGNMSF overview →